Top Biotechnology companies in United States by Price to Sales Ratio (P/S)
United States
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
184,503,984.00 |
Jan. 14, 2025 | USD 2.66 | NA |
|
United States |
|
| 2 |
40,164.37 |
Jan. 14, 2025 | USD 10.38 | -0.10% |
|
United States |
|
| 3 |
29,258.97 |
Jan. 14, 2025 | USD 12.06 | -1.63% |
|
United States |
|
| 4 |
15,578.39 |
Jan. 14, 2025 | USD 14.62 | -8.62% |
|
United States |
|
| 5 |
11,499.83 |
Jan. 14, 2025 | USD 2.00 | -5.66% |
|
United States |
|
| 6 |
10,613.47 |
Jan. 14, 2025 | USD 2.10 | -0.47% |
|
United States |
|
| 7 |
10,296.97 |
Jan. 14, 2025 | USD 15.99 | NA |
|
United States |
|
| 8 |
9,919.66 |
Jan. 14, 2025 | USD 39.83 | -6.44% |
|
United States |
|
| 9 |
9,362.10 |
Jan. 14, 2025 | USD 1.92 | -1.54% |
|
United States |
|
| 10 |
8,672.07 |
Jan. 14, 2025 | USD 33.93 | -12.73% |
|
United States |
|
| 11 |
8,521.27 |
Jan. 14, 2025 | USD 6.23 | -8.11% |
|
United States |
|
| 12 |
5,375.03 |
Jan. 14, 2025 | USD 21.87 | -3.36% |
|
United States |
|
| 13 |
4,715.37 |
Jan. 14, 2025 | USD 4.72 | -0.63% |
|
United States |
|
| 14 |
4,422.27 |
Jan. 14, 2025 | USD 16.86 | -5.12% |
|
United States |
|
| 15 |
3,918.10 |
Jan. 14, 2025 | USD 0.99 | -3.87% |
|
United States |
|
| 16 |
3,293.60 |
Jan. 14, 2025 | USD 3.17 | -0.94% |
|
United States |
|
| 17 |
3,179.32 |
Jan. 14, 2025 | USD 35.62 | -8.62% |
|
United States |
|
| 18 |
3,155.62 |
Jan. 14, 2025 | USD 6.28 | -0.47% |
|
United States |
|
| 19 |
3,143.74 |
Jan. 14, 2025 | USD 5.96 | -8.87% |
|
United States |
|
| 20 |
2,288.63 |
Jan. 14, 2025 | USD 6.37 | 0.63% |
|
United States |
|
| 21 |
2,271.95 |
Jan. 14, 2025 | USD 20.46 | -7.29% |
|
United States |
|
| 22 |
2,238.96 |
Jan. 14, 2025 | USD 22.88 | 0.57% |
|
United States |
|
| 23 |
2,090.08 |
Jan. 14, 2025 | USD 1.71 | -1.16% |
|
United States |
|
| 24 |
1,995.50 |
Jan. 14, 2025 | USD 3.93 | -1.50% |
|
United States |
|
| 25 |
1,906.98 |
Jan. 14, 2025 | USD 3.37 | 1.81% |
|
United States |
|
| 26 |
1,702.50 |
Jan. 14, 2025 | USD 10.53 | -2.95% |
|
United States |
|
| 27 |
1,658.21 |
Jan. 14, 2025 | USD 45.23 | -3.17% |
|
United States |
|
| 28 |
1,606.80 |
Jan. 14, 2025 | USD 15.94 | 5.56% |
|
United States |
|
| 29 |
1,332.16 |
Jan. 14, 2025 | USD 5.10 | -1.92% |
|
United States |
|
| 30 |
1,269.18 |
Jan. 14, 2025 | USD 2.10 | -2.33% |
|
United States |
|
| 31 |
1,203.69 |
Jan. 14, 2025 | USD 20.80 | -3.48% |
|
United States |
|
| 32 |
1,157.12 |
Jan. 14, 2025 | USD 27.52 | 8.65% |
|
United States |
|
| 33 |
1,092.72 |
Jan. 14, 2025 | USD 25.38 | 0.87% |
|
United States |
|
| 34 |
851.42 |
Jan. 14, 2025 | USD 2.08 | -5.02% |
|
United States |
|
| 35 |
776.55 |
Jan. 14, 2025 | USD 12.48 | -2.65% |
|
United States |
|
| 36 |
764.56 |
Jan. 14, 2025 | USD 65.84 | 2.84% |
|
United States |
|
| 37 |
713.84 |
Jan. 14, 2025 | USD 0.82 | -9.33% |
|
United States |
|
| 38 |
712.86 |
Jan. 14, 2025 | USD 4.70 | -1.47% |
|
United States |
|
| 39 |
674.18 |
Jan. 14, 2025 | USD 78.14 | -3.73% |
|
United States |
|
| 40 |
646.57 |
Jan. 14, 2025 | USD 0.57 | -9.14% |
|
United States |
|
| 41 |
641.78 |
Jan. 14, 2025 | USD 3.20 | -5.88% |
|
United States |
|
| 42 |
632.51 |
Jan. 14, 2025 | USD 18.05 | -4.55% |
|
United States |
|
| 43 |
608.10 |
Jan. 14, 2025 | USD 17.20 | -4.55% |
|
United States |
|
| 44 |
551.07 |
Jan. 14, 2025 | USD 1.72 | 1.09% |
|
United States |
|
| 45 |
543.64 |
Jan. 14, 2025 | USD 1.28 | -1.54% |
|
United States |
|
| 46 |
532.27 |
Jan. 14, 2025 | USD 42.54 | -1.21% |
|
United States |
|
| 47 |
524.00 |
Jan. 14, 2025 | USD 2.47 | -1.20% |
|
United States |
|
| 48 |
501.01 |
Jan. 14, 2025 | USD 22.74 | -1.00% |
|
United States |
|
| 49 |
483.04 |
Jan. 14, 2025 | USD 1.81 | 4.02% |
|
United States |
|
| 50 |
469.86 |
Jan. 14, 2025 | USD 1.22 | -3.17% |
|
United States |
Frequently Asked Questions
-
Which Biotechnology company in United States has the highest Price to Sales Ratio (P/S) ?
The Biotechnology company in United States with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
-
Which Biotechnology company in United States has the lowest Price to Sales Ratio (P/S) ?
The Biotechnology company in United States with the lowest Price to Sales Ratio (P/S) is Lipella Pharmaceuticals Inc. (NasdaqCM: LIPO) at 0.03.
-
What are the top 10 Biotechnology companies in United States by Price to Sales Ratio (P/S) ?
The top 10 Biotechnology companies in United States by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Benitec Biopharma Inc., Greenwich LifeSciences, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Cadrenal Therapeutics, Inc. Common Stock, Revolution Medicines, Inc., Allogene Therapeutics, Inc. and Viking Therapeutics, Inc..
-
What are the bottom 10 Biotechnology companies in United States by Price to Sales Ratio (P/S) ?
The bottom 10 Biotechnology companies in United States by Price to Sales Ratio (P/S) are Lipella Pharmaceuticals Inc., Benson Hill, Inc., Radius Health, Inc., Danimer Scientific, Inc., 22nd Century Group, Inc., Biofrontera Inc., iSpecimen Inc., Inotiv, Inc., CAMP4 Therapeutics Corporation and STRATA Skin Sciences, Inc..